DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

A Tailored Program to Promote Well-being and Physical Activity in Mid-life Adults With Low Physical Activity

Not Applicable

Completed

Conditions: Middle Aged
Exercise

Interventions: Behavioral: MASTERY

First Posted Date: 2021-02-09

Last Posted Date: 2021-02-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 11

Registration Number: NCT04745182

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM

Completed

Conditions: Vulvovaginal Atrophy
Menopause
Genitourinary Syndrome of Menopause

First Posted Date: 2021-02-09

Last Posted Date: 2025-05-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 210

Registration Number: NCT04746456

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition

Not Applicable

Completed

Conditions: Feeding Patterns
Sleep
Glucose Intolerance
Short Bowel Syndrome

Interventions: Dietary Supplement: Time-of-day of parenteral nutrition provision

First Posted Date: 2021-02-08

Last Posted Date: 2024-01-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT04743960

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Pulmonary Physiologic Assessment of Patients on Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)

Withdrawn

Conditions: Cardiac Arrest
Pulmonary Injury

First Posted Date: 2021-02-04

Last Posted Date: 2022-11-10

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT04739007

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU

Not Applicable

Recruiting

Conditions: Glucose Intolerance
Feeding Patterns
Sleep

Interventions: Dietary Supplement: Time-of-day of enteral nutrition provision (nighttime first)
Dietary Supplement: Time-of-day of enteral nutrition provision (daytime first)

First Posted Date: 2021-02-03

Last Posted Date: 2025-05-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT04737200

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Phase 1

Completed

Conditions: Cutaneous Neurofibroma

Interventions: Device: 755nm Alexandrite Laser
Device: 1064nm laser
Drug: Kybella

First Posted Date: 2021-01-29

Last Posted Date: 2025-02-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 34

Registration Number: NCT04730583

Locations: 🇺🇸
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, United States

Pembrolizumab And Lenvatinib In Leptomeningeal Metastases

Phase 2

Terminated

Conditions: Solid Tumor
Solid Tumor, Adult
Leptomeningeal Metastasis

Interventions: Drug: Pembrolizumab
Drug: Lenvatinib

First Posted Date: 2021-01-28

Last Posted Date: 2024-03-15

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 10

Registration Number: NCT04729348

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings

Not Applicable

Completed

Conditions: Covid19
Intellectual Disability
Mental Illness
Coronavirus
Developmental Disability
Axis I Diagnosis

Interventions: Behavioral: Generic Best Practices
Behavioral: Tailored Best Practices

First Posted Date: 2021-01-27

Last Posted Date: 2025-02-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 415

Registration Number: NCT04726371

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

The Effect of Opioid-Free Anesthesia in TMJ Surgery

Phase 2

Completed

Conditions: Temporomandibular Joint Disorders

Interventions: Drug: Dexmedetomidine / Ketamine / Lidocaine

First Posted Date: 2021-01-26

Last Posted Date: 2024-11-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT04724759

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Enhancing Resilience in Senior Living Community Residents

Not Applicable

Conditions: Stress, Psychological
Coping Skills

Interventions: Behavioral: SMART-3RP Group Intervention

First Posted Date: 2021-01-22

Last Posted Date: 2021-09-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 80

Registration Number: NCT04720014

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy